1Otsuji E,Kuriu Y,Ichikara D,et al.Tumor recurrence and its timing following curative resection of early gastric carcinoma.Anticancer Res,2003,23:3499-3503. 被引量：1
2Yoshikawa T,Tsuburaya A,Kobayashi 0,et al.Is D2 lymphnode dissection necessary for early gastric cancer? Ann Surg Oncology,2002,9:401-405. 被引量：1
3Yonemura Y.Controversies in surgical treatment of gastric cancer.Gan To Kagaku Ryoho,2003,30(9):1238-1248. 被引量：1
4Japanese Gastric Cancer Association Registration Committee,Maruy-ama K,Kaminishi M,et al.Gastric captor treated in 1991 in Japan:data analysis of nationwide registry.Gastric Cancer,2006,9(2):51-66. 被引量：1
5Schwarz RE,Smith DD.Clinical impact of lymphadenectomy extent in resectable gastric cancer of advanced stage.Ann surg Oncol,2007,14(2):317-328. 被引量：1
6Jong-Han Kim,You-Jin Jang.Surgical outcomes and prognostic factors for T4 gastric cancers.Asian J Surg,2009,32(4):198-204. 被引量：1
7P Sun,J Xiang,Z Chen,et al.Meta-analysis of adjuvant chemotherapy after radical surgery for advanced gastric cancer.British Journal of Surgery,2009,96:26-33. 被引量：1
8He RB,Chen JQ.Pre-operative Chemotherapy for Gastric Cancer.J Int Med Res,2009,37(5):1259-1266. 被引量：1
9C Schuhmacher,P Schlag,F Lordick,et al.Neoadjuvant chemotherapy versus surgery alone for locally advanced adenocarcinoma of the stomach and cardia:Randomized EORTC phase III trial #40954.Journal of Clinical Oncology,2009,27(15):4510. 被引量：1
10Back MF,Premsenthil S,Wynne CJ,et al.Introducing the Intergroup 0116 protocol of adjuvant chemo-radiotherapy in gastric cancer into clinical practice.Clin Oncol(R Coll Radiol),2003,15(7):378-382. 被引量：1
3Marrelli D,Pedrazzani C, Neri A,et al.Complications after extended (I)2) and superextended (133) lymphadenectomy for gastric cancer: analysis of potential risk factors[J]. Ann Surg 0ncol,2007,14(1) :25-33. 被引量：1
4Jeong O,Park YK, Ryu SY, et al. Effect of age on surgical outcomes of extended gastrectomy with D2 lymph node dissection in gastric carcinoma:prospective cohort study [J]. Ann Surg Oneol,2010,17(6):1589-1596. 被引量：1
5Fertay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: Source, methods and major patterns in GLOBOCAN 2012[J3. Int J Cancer, 2015,136:E359-E386. 被引量：1
6Olefson S, Moss SF. Obesity and related risk factors in gastric cardia adenocarcinoma[J]. Gastric Cancer, 2015,18 : 23-32. 被引量：1
7da Costa DM, Dos Santos Pereira E, de Lima Silva-Fernandes IJ, et al. Characterization of gastric cardia tumors: differences in helicobacter pylori strains and Genetic po|ymorpbisms [J~. Dig Dis Sci, 2015,60:2712-2717. 被引量：1
8Bass A J, Thorsson V, Shmulevich I, et al. Comprehensive molecular characterization of gastric adenocarcinoma [Jl. Nature, 2014,513 : 202-209. 被引量：1
9Murphy G, Pfeiffer R, Camargo MC, et al. Meta-analysisshows that prevalence of epstein-barr virus-positive gastric cancer differs based on sex and anatomic location [J]. Gastroenterology, 2009,137:824-833. 被引量：1
10Wilkinson NW, Howe J, Gay G, et al. Differences in the pattern of presentation and treatment of proximal and distal gastric cancer: results of the 2001 gastric patient care evaluation[J]. Ann Surg Oncol, 2008, 15:1644-1650. 被引量：1
